CIK 0001737287
- Non-accelerated filer
- Smaller reporting company
Allogene Therapeutics, Inc.
Sign in to watch- Ticker
- ALLO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 823562771
- Phone
- +1 650-457-2700
- Business address
- 210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,698
- in 1 filing
Net −$48,698. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-02 | Belldegrun Arie Director | Grant or award · Stock Option (Right to buy) | +929,913 | 929,913 | ||
| 2026-02-02 | Belldegrun Arie Director | Grant or award · Restricted Stock Unit | +263,033 | 263,033 | ||
| 2025-01-24 | Belldegrun Arie Director | Grant or award | +369,957 | 2,236,816 | ||
| 2025-01-24 | Belldegrun Arie Director | Grant or award · Stock Option (Right to buy) | +1,307,927 | 1,307,927 | ||
| 2024-05-16 | Belldegrun Arie Director | Grant or award | +344,828 | $2.90 | $1.0M | 539,867 |
| 2024-05-16 | Belldegrun Arie Director | Purchase | +1,724,137 | $2.90 | $5.0M | 1,724,137 |
| 2024-01-25 | Belldegrun Arie Director | Grant or award | +211,973 | 1,866,859 | ||
| 2024-01-25 | Belldegrun Arie Director | Grant or award · Stock Option (Right to buy) | +749,398 | 749,398 | ||
| 2023-03-22 | Belldegrun Arie Director | Grant or award | +1,282,976 | 1,654,886 | ||
| 2023-03-22 | Belldegrun Arie Director | Grant or award · Stock Option (Right to Buy) | +994,800 | 994,800 | ||
| 2022-03-23 | Belldegrun Arie Director | Grant or award · Stock Option (Right to Buy) | +1,458,333 | 1,458,333 | ||
| 2022-03-14 | Belldegrun Arie Director | Other disposition | −4,710,120 | 0 | ||
| 2022-03-14 | Belldegrun Arie Director | Other acquisition | +4,710,120 | 4,710,120 | ||
| 2022-03-14 | Belldegrun Arie Director | Other disposition | −4,710,121 | 0 | ||
| 2022-03-14 | Belldegrun Arie Director | Other acquisition | +4,710,121 | 4,710,121 | ||
| 2022-01-12 | Belldegrun Arie Director | Purchase | +155,039 | $12.60 | $2.0M | 195,039 |
| 2021-05-24 | Belldegrun Arie Director | Exercise or conversion | +379,066 | $18.22 | $6.9M | 583,034 |
| 2021-05-24 | Belldegrun Arie Director | Exercise or conversion · Stock Option (Right to Buy) | −379,066 | 0 | ||
| 2021-03-26 | Belldegrun Arie Director | Grant or award | +53,635 | 203,968 | ||
| 2021-03-26 | Belldegrun Arie Director | Grant or award · Stock Option (Right to Buy) | +199,223 | 199,223 |
Page 1 of 2 · 37 trades